# FDA 483 - Glenmark Pharmaceuticals Ltd - February 14, 2025

Source: https://www.globalkeysolutions.net/records/483/glenmark-pharmaceuticals-ltd/0ced202b-767c-4244-95f5-a3ab861a6b47

> FDA 483 for Glenmark Pharmaceuticals Ltd on February 14, 2025. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Glenmark Pharmaceuticals Ltd
- Inspection Date: 2025-02-14
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [483 - 2018-05-24](https://www.globalkeysolutions.net/records/483/glenmark-pharmaceuticals-ltd/7fe7f73b-7011-4b70-82e3-f637a3a418ec)
- [WARNING_LETTER - 2025-02-14](https://www.globalkeysolutions.net/records/warning_letter/glenmark-pharmaceuticals-ltd/f05498db-6645-42ab-81ff-8a03eb201f2f)
- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/glenmark-pharmaceuticals-ltd/e1b15e7f-18f1-4ff7-818d-017c48380a7b)

## Related Officers

- [Saleem A. Akhtar](https://www.globalkeysolutions.net/people/saleem-a-akhtar/1ea49212-bea5-4d43-bd0a-cdede4d3b1cf)
- [Consumer Safety Officer - Dedicated Foreign Drug Cadre](https://www.globalkeysolutions.net/people/tamil-arasu/94efc491-7d9f-4221-a1ee-69a925acb1c3)

Company: https://www.globalkeysolutions.net/companies/glenmark-pharmaceuticals-ltd/1e6c03ca-7a68-4506-9af3-70d64338538a

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c